NCT06337331 Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell Transplant Status WITHDRAWN Phase PHASE2
NCT06315309 Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant Status RECRUITING Phase PHASE2
NCT06304103 A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome Status RECRUITING Phase PHASE2
NCT06303193 Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms Status RECRUITING Phase PHASE1/PHASE2
NCT06279494 Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT06279338 A Novel Conditioning Regimen for Myelodysplastic Syndrome With Moderate High IPSS-M Score Status NOT_YET_RECRUITING Phase NA
NCT06270771 OURA Ring Wearable Testing in MDS Patients: a Feasibility and Discovery Pilot Study Status RECRUITING Phase N/A
NCT06247917 Evaluate the Efficacy and Safety of Allogeneic Haematopoietic Stem Cell Transplantation With FBM Conditioning for MDS Status RECRUITING Phase PHASE2
NCT06244173 Clinical and Laboratory Parameters of Myelodysplastic Syndromes at Upper Egypt Status COMPLETED Phase N/A
NCT06235398 Upfront Related Donor Transplantation in Patients With Myelodisplatic Syndrome : a Phase 2 Trial Status NOT_YET_RECRUITING Phase PHASE2
NCT06218771 A Study of TQB3454 Tablets in Patients With Blood Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06206174 TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT06146257 A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes Status RECRUITING Phase PHASE1
NCT06144515 Collection of Samples of Bone Marrow Aspiration From Patients With Myelodysplastic Syndrome Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06138587 Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation Status RECRUITING Phase PHASE1
NCT06113302 A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS) Status RECRUITING Phase PHASE2